607 related articles for article (PubMed ID: 2196522)
1. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
[TBL] [Abstract][Full Text] [Related]
2. Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder.
Pelham WE; Sturges J; Hoza J; Schmidt C; Bijlsma JJ; Milich R; Moorer S
Pediatrics; 1987 Oct; 80(4):491-501. PubMed ID: 3658567
[TBL] [Abstract][Full Text] [Related]
3. American Academy of Pediatrics Committee on Children with Disabilities, Committee on Drugs: Medication for children with an attention deficit disorder.
Pediatrics; 1987 Nov; 80(5):758-60. PubMed ID: 3670981
[No Abstract] [Full Text] [Related]
4. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
Conners CK
Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
[No Abstract] [Full Text] [Related]
5. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
6. Sustained-release methylphenidate: new preparations. New pharmaceutical forms: a slight advantage for a small number of children.
Prescrire Int; 2004 Dec; 13(74):203-6. PubMed ID: 15612099
[TBL] [Abstract][Full Text] [Related]
7. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
Varley CK; Vincent J; Varley P; Calderon R
Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
[TBL] [Abstract][Full Text] [Related]
8. Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder.
Fitzpatrick PA; Klorman R; Brumaghim JT; Borgstedt AD
J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):226-34. PubMed ID: 1564023
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.
Handen BL; Breaux AM; Gosling A; Ploof DL; Feldman H
Pediatrics; 1990 Dec; 86(6):922-30. PubMed ID: 2135682
[TBL] [Abstract][Full Text] [Related]
10. Pemoline (Cylert) for minimal brain dysfunction.
Med Lett Drugs Ther; 1976 Jan; 18(2):5-6. PubMed ID: 1107790
[No Abstract] [Full Text] [Related]
11. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
[TBL] [Abstract][Full Text] [Related]
12. The use of stimulant medication with children.
Phillips S
J Dev Behav Pediatr; 1989 Dec; 10(6):319-20. PubMed ID: 2600187
[No Abstract] [Full Text] [Related]
13. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
14. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
[TBL] [Abstract][Full Text] [Related]
15. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children.
Swanson J; Gupta S; Guinta D; Flynn D; Agler D; Lerner M; Williams L; Shoulson I; Wigal S
Clin Pharmacol Ther; 1999 Sep; 66(3):295-305. PubMed ID: 10511066
[TBL] [Abstract][Full Text] [Related]
16. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.
Stevenson RD; Wolraich ML
Pediatr Clin North Am; 1989 Oct; 36(5):1183-97. PubMed ID: 2677938
[TBL] [Abstract][Full Text] [Related]
17. Stimulant medication and short attention span: a clinical approach.
Davy T; Rodgers CL
J Dev Behav Pediatr; 1989 Dec; 10(6):313-8. PubMed ID: 2513337
[TBL] [Abstract][Full Text] [Related]
18. Comparison of sustained-release and standard methylphenidate in the treatment of minimal brain dysfunction.
Whitehouse D; Shah U; Palmer FB
J Clin Psychiatry; 1980 Aug; 41(8):282-5. PubMed ID: 7400107
[TBL] [Abstract][Full Text] [Related]
19. Treatment of attention-deficit/hyperactivity disorder.
Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
[TBL] [Abstract][Full Text] [Related]
20. Testing the ability of children with attention deficit hyperactivity disorder to accurately report the effects of medication on their behavior.
Ardoin SP; Martens BK
J Appl Behav Anal; 2000; 33(4):593-610. PubMed ID: 11214033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
